文献速递糖尿病

年龄和抗体类型对1型糖尿病亲属从单一自身抗体进展为多种自身抗体的影响

Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

研究基于TrialNet Pathway to Prevention前瞻性随访994例血糖正常且单一自身抗体阳性的1型糖尿病亲属,每6至12个月检测抗体,中位随访2年。5年进展风险与年龄负相关,但模式因抗体类型而异:GADA阳性者风险随四年龄组逐渐下降,IAA阳性者8岁后急剧下降。递归分割分析确定GADA年龄断点14岁、IAA为4岁。

要点

  • GADA阳性亲属5年多抗体风险随年龄逐渐下降,IAA阳性者8岁后急剧下降。
  • 递归分割分析确定GADA年龄断点14岁、IAA年龄断点4岁。
  • IAA阳性者自身免疫扩散主要限于幼儿期,GADA初始免疫反应可成熟更长时间。

核心结论

  • IAA阳性亲属的胰岛自身免疫扩散主要限于幼儿期,而初始针对谷氨酸脱羧酶的免疫反应可在更长时期成熟。
  • 这些差异对监测这些患者和设计预防试验具有重要启示。

研究设计与样本

  • 前瞻性队列研究,纳入TrialNet Pathway to Prevention中994例血糖正常且单一自身抗体阳性的1型糖尿病亲属。
  • 每6至12个月检测GADA、IAA、胰岛素瘤相关抗原2、锌转运体8自身抗体及胰岛细胞抗体。
  • 主要结局为确认出现多种自身抗体;年龄分为<8岁、8至11岁、12至17岁、≥18岁四组,并通过递归分割分析确定最佳年龄断点。

主要发现

  • 中位随访2年,141例亲属出现至少一种额外自身抗体。
  • 5年风险与年龄呈负相关,但模式因抗体类型而异:GADA阳性亲属在四个年龄组中风险逐渐下降,IAA阳性亲属8岁后急剧下降。
  • 递归分割分析确定GADA阳性亲属年龄断点为14岁,IAA阳性亲属年龄断点为4岁。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Islet autoantibodies are markers of type 1 diabetes, and an increase in number of autoantibodies detected during the preclinical phase predicts progression to overt disease. OBJECTIVE: To refine the effect of age in relation to islet antibody type on progression from single to multiple autoantibodies in relatives of people with type 1 diabetes. RESEARCH DESIGN AND METHODS: We examined 994 relatives with normal glucose tolerance who were positive for a single autoantibody, followed prospectively in the TrialNet Pathway to Prevention. Antibodies to glutamic acid decarboxylase (GADA), insulin (IAA), insulinoma-associated antigen 2, and zinc transporter 8 and islet cell antibodies were tested every 6 to 12 months. The primary outcome was confirmed development of multiple autoantibodies. Age was categorized as <8 years, 8 to 11 years, 12 to 17 years, and ≥18 years, and optimal age breakpoints were identified by recursive partitioning analysis. RESULTS: After median follow-up of 2 years, 141 relatives had developed at least one additional autoantibodies. Five-year risk was inversely related to age, but the pattern differed by antibody type: Relatives with GADA showed a gradual decrease in risk over the four age groups, whereas relatives with IAA showed a sharp decrease above age 8 years. Recursive partitioning analysis identified age breakpoints at 14 years in relatives with GADA and at 4 years in relatives with IAA. CONCLUSIONS: In relatives with IAA, spread of islet autoimmunity is largely limited to early childhood, whereas immune responses initially directed at glutamic acid decarboxylase can mature over a longer period. These differences have important implications for monitoring these patients and for designing prevention trials.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Bosi E, Boulware DC, Becker DJ, et al. Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives. J Clin Endocrinol Metab. 2017. PMID: 28531305. doi:10.1210/jc.2017-00569

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。